ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 294734 7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- 0.0350615470435428 -0.3251346
NSC 316158 Null 0.0350615470435428 -0.053729753
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0350615470435428 0.025945413
NSC 359892 2,6-Epoxy-2H-1-benzoxocin-5(6H)-one, 6,8-dimethyl- 0.0350615470435428 -0.11490712
NSC 363812 Tetraplatin 0.0350615470435428 0.30170194
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0350615470435428 0.0083350979
NSC 373980 Null 0.0350615470435428 0.29455193
NSC 380721 Eremantholide B 0.0350615470435428 0.063899695
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0350615470435428 -0.26354689
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0350615470435428 -0.13044629
Total:119  Current:81    [First] [Prev] [Next] [Last]